Ifsofamide and Macrobid drug interactions - a phase IV clinical study of FDA data
Summary:
We study 9,219 people who take Ifsofamide (ifosfamide) and Macrobid (nitrofurantoin; nitrofurantoin, macrocrystalline). There is no drug interaction reported.
The study analyzes what interactions people have when they take Ifsofamide and Macrobid. It is created by eHealthMe based on reports the from the FDA, and is updated regularly.
What is Ifsofamide?
Ifsofamide has active ingredients of ifosfamide. eHealthMe is studying from 5 Ifsofamide users. Check the latest studies of Ifsofamide.
What is Macrobid?
Macrobid has active ingredients of nitrofurantoin; nitrofurantoin, macrocrystalline. It is often used in urinary tract infection. eHealthMe is studying from 9,214 Macrobid users. Check the latest studies of Macrobid.
No report is found.
Do you take Ifsofamide and Macrobid?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Ifsofamide (5 reports)
- Macrobid (9,214 reports)
How the study uses the data?
The study uses data from the FDA. It is based on ifosfamide and nitrofurantoin; nitrofurantoin, macrocrystalline (the active ingredients of Ifsofamide and Macrobid, respectively), and Ifsofamide and Macrobid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Fenofibrate cause Cerebral Disorder? - 3 seconds ago
- Memory Loss and Epilepsy - 4 seconds ago
- Could Ondansetron cause Diabetic Retinopathy? - 10 seconds ago
- Nasal Disorder and drugs of ingredients of montelukast sodium - 18 seconds ago
- Drug interactions of Imodium and Fosinopril Sodium - 18 seconds ago
- Could Abilify cause Body Temperature Fluctuation? - 20 seconds ago
- Spinal X-Ray Abnormal and drugs of ingredients of sulfasalazine - 24 seconds ago
- Levemir vs. Symlin, side effect and effectiveness comparison - 26 seconds ago
- Drug interactions of Aimovig and Methylprednisolone Sodium Succinate - 36 seconds ago
- Could Alendronate Sodium cause Nasal Obstruction? - 42 seconds ago